These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23357031)

  • 1. Comparison of driving simulator performance with real driving after alcohol intake: a randomised, single blind, placebo-controlled, cross-over trial.
    Helland A; Jenssen GD; Lervåg LE; Westin AA; Moen T; Sakshaug K; Lydersen S; Mørland J; Slørdal L
    Accid Anal Prev; 2013 Apr; 53():9-16. PubMed ID: 23357031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of measures of impairment in real and simulated driving: Results from a randomized, placebo-controlled study.
    Helland A; Jenssen GD; Lervåg LE; Moen T; Engen T; Lydersen S; Mørland J; Slørdal L
    Traffic Inj Prev; 2016; 17(3):245-50. PubMed ID: 26147898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alcohol on highway driving in the STISIM driving simulator.
    Mets MA; Kuipers E; de Senerpont Domis LM; Leenders M; Olivier B; Verster JC
    Hum Psychopharmacol; 2011 Aug; 26(6):434-9. PubMed ID: 21823173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driving simulator sickness: Impact on driving performance, influence of blood alcohol concentration, and effect of repeated simulator exposures.
    Helland A; Lydersen S; Lervåg LE; Jenssen GD; Mørland J; Slørdal L
    Accid Anal Prev; 2016 Sep; 94():180-7. PubMed ID: 27322638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance.
    Iwata M; Iwamoto K; Kitajima I; Nogi T; Onishi K; Kajiyama Y; Nishino I; Ando M; Ozaki N
    Psychopharmacology (Berl); 2021 Mar; 238(3):775-786. PubMed ID: 33236169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild to moderate dehydration combined with moderate alcohol consumption has no influence on simulated driving performance.
    Irwin C; Leveritt M; Shum DH; Desbrow B
    Traffic Inj Prev; 2014; 15(6):652-62. PubMed ID: 24867575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorazepam impairs highway driving performance more than heavy alcohol consumption.
    Daurat A; Sagaspe P; Moták L; Taillard J; Bayssac L; Huet N; Authié C; Mestre D; Philip P
    Accid Anal Prev; 2013 Nov; 60():31-4. PubMed ID: 24007754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute alcohol consumption on measures of simulated driving: A systematic review and meta-analysis.
    Irwin C; Iudakhina E; Desbrow B; McCartney D
    Accid Anal Prev; 2017 May; 102():248-266. PubMed ID: 28343124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of two doses of alcohol on simulator driving performance in adults with attention-deficit/hyperactivity disorder.
    Barkley RA; Murphy KR; O'Connell T; Anderson D; Connor DF
    Neuropsychology; 2006 Jan; 20(1):77-87. PubMed ID: 16460224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.
    Thompson I; Williams G; Caldwell B; Aldington S; Dickson S; Lucas N; McDowall J; Weatherall M; Robinson G; Beasley R
    J Psychopharmacol; 2010 Sep; 24(9):1299-308. PubMed ID: 19329546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further development of a commercial driving simulation for research in occupational medicine.
    Muttray A; Breitinger A; Goetze E; Schnupp T; Geissler B; Kaufmann T; Golz M; Letzel S
    Int J Occup Med Environ Health; 2013 Dec; 26(6):949-65. PubMed ID: 24464572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and nature of stopped on-the-road driving tests and the relationship with objective performance impairment.
    Verster JC; Roth T
    Accid Anal Prev; 2012 Mar; 45():498-506. PubMed ID: 22269535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic.
    Ramaekers G; Lamers J; Verhey F; Muntjewerff D; Mobbs E; Sanders N; Lewis M; Lockton A
    Psychopharmacology (Berl); 2002 Jan; 159(2):203-10. PubMed ID: 11862350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
    van de Loo AJAE; Bervoets AC; Mooren L; Bouwmeester NH; Garssen J; Zuiker R; van Amerongen G; van Gerven J; Singh J; der Ark PV; Fedgchin M; Morrison R; Wajs E; Verster JC
    Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol use patterns and their association with sober driver vehicle control in high fidelity driving simulation.
    Banz BC; Brown TL; Camenga DR; Li K; Vaca FE
    Traffic Inj Prev; 2020 Oct; 21(sup1):S150-S154. PubMed ID: 33179979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged nocturnal driving can be as dangerous as severe alcohol-impaired driving.
    Verster JC; Taillard J; Sagaspe P; Olivier B; Philip P
    J Sleep Res; 2011 Dec; 20(4):585-8. PubMed ID: 21226780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
    Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
    Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
    Kuypers KP; Samyn N; Ramaekers JG
    Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.